Detalles de la búsqueda
1.
Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
BJU Int
; 124(2): 221-241, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30653801
2.
Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
BJU Int
; 121(5): 703-715, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29211320
3.
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
Cancer
; 121(8): 1328-38, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25529384
4.
Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune-checkpoint inhibitors.
Drugs Context
; 122023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37378080
5.
Consensus Statements on Precision Oncology in the China Greater Bay Area.
JCO Precis Oncol
; 7: e2200649, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315266
6.
Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.
Asia Pac J Clin Oncol
; 17 Suppl 3: 48-54, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860643
7.
Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
Asia Pac J Clin Oncol
; 17 Suppl 3: 12-26, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860645
8.
Revisiting the role of bone-modifying agents in the management of metastatic prostate cancer.
Asia Pac J Clin Oncol
; 14 Suppl 5: 13-15, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30489032
9.
Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC).
Am J Clin Oncol
; 39(6): 609-613, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24977690
10.
Hong Kong consensus recommendations on the management of hepatocellular carcinoma.
Liver Cancer
; 4(1): 51-69, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26020029
11.
The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT.
Oral Oncol
; 50(5): 506-12, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24529762
12.
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.
J Clin Oncol
; 32(25): 2765-72, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25049330
13.
Risk factors and natural history of breast cancer in younger Chinese women.
World J Clin Oncol
; 5(5): 1097-106, 2014 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25493246
14.
Definitive radiotherapy for early stage glottic cancer by 6 MV photons.
Head Neck Oncol
; 4: 23, 2012 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-22607730
15.
Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.
Radiat Oncol
; 6: 53, 2011 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21600025
16.
Cutaneous indeterminate dendritic cell tumor with a protracted relapsing clinical course.
Am J Surg Pathol
; 33(8): 1261-3, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19471157
Resultados
1 -
16
de 16
1
Próxima >
>>